Table 3.

Characteristics of the experts that participated in the scenario drafting questionnaire (n = 29)

Number of respondents	29 (100%)
Function
Medical oncologist	22 (76%)
Director	3 (10%)
Head cell production	1 (3%)
Consultant	1 (3%)
Clinical and translational research	2 (7%)
Mean experience with melanoma, years (range)	16.38 (1–35)
Mean experience with TIL therapy, years (range)	2.72 (0–20)
Level of familiarity with TIL therapy
Unfamiliar	0 (0%)
Accidentally familiar	3 (10%)
Familiar	15 (52%)
Former expert	3 (10%)
Expert	8 (28%)
Employed in:
Australia	1 (3%)
Belgium	1 (3%)
Denmark	2 (7%)
Germany	3 (10%)
Israel	1 (3%)
Italy	1 (3%)
Netherlands	14 (48%)
Poland	1 (3%)
Portugal	1 (3%)
Spain	1 (3%)
UK	1 (3%)
US	1 (3%)
N/A	1 (3%)